Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)

Condition:   Staphylococcal InfectionIntervention:   Drug: MupirocinSponsor:   Destiny Pharma LtdCompleted - verified November 2014

Source: ClinicalTrials.gov - October 21, 2014 Category: Research Source Type: clinical trials